CU in the News

Thailand’s search for vaccines and the hurdles the country still faces

Thailand places much of its hope on local vaccine development – namely the BioNet, Chulalongkorn University, and Baiya Phytopharm vaccines. Although their efficacy is yet to be known, it is clearly much slower in the works. The Chulalongkorn University mRNA vaccine, for instance, is estimated to start the first phase of clinical trials in April and be ready by the end of 2021. The University has also turned to a fundraising “Covid-19 Vaccine for Thais” campaign in an effort to cope with the costs.

Chula produces able graduates who become quality citizens for society.

Prof. Bundhit Eua-arporn President of Chulalongkorn University